Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Evelo Biosciences Inc

(NASDAQ: EVLO)
Add to Portfolio
-0.16 (-2.39%)
as of Oct 18, 2019

Profile
Ticker Symbol EVLO
Exchange NASDAQ
Contact Information
620 Memorial Drive Suite 500 West
Cambridge, MA USA
P: 617-577-0300
CEO/President Balkrishan (Simba) Gill
Earnings at a Glance
Earnings 06/30/19
-0.65
03/31/19
-0.64
12/31/18
1.86
09/30/18
-0.50
Price Earnings Ratio N/A
EPS Growth 11.39
Most Recent Earnings ($) -0.65
Annual EPS ($) -2.28
Business Summary
Evelo Biosciences Inc. operates as a bio-technology company. It develops therapies for the treatment of the gut-body network. The company also offers treatment for cancer and inflammatory diseases. Its product portfolio consists of EDP1066 which are in clinical stage. Evelo Biosciences is based in Massachusetts United States.
Industry/Sector SIC-2834 Pharmaceutical Preparations
Medical - Biomedical
Indices Russell 3000
Indices Russell 2000